IRCT20190226042851N1
Completed
Phase 3
Evaluation of the effect of inhaled solution based on silver colloid with the brand name colloide silver nasal spray 10ppm to control COVID-19-induced lung infection and increase patients' respiratory volume
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Positive PCR test
- •The patient is not COPD
- •Not having acute kidney problems
- •The patient does not have Acute liver failure
- •18 years and older
- •The patient does not need ventilator therapy
- •The patient has low respiratory capacity
- •The patient has covide\-19
Exclusion Criteria
- •The patient is hospitalized for less than seven days
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Survey and comparison the effect of inhalation of lavender on nausea, vomiting and pain after hernia surgeryVentral herniaCondition 1: Inguinal hernia. Condition 2: Femoral hernia. Condition 3: Umbilical hernia. Condition 4: Ventral hernia.Inguinal herniaFemoral herniaUmbilical herniaIRCT201602103064N1Vice chancellor for research of Shahroud University of Medical Sciences110
Not yet recruiting
Not Applicable
aromatherapy with spirit and ginger oil for control of nausea and vomiting in postoperative patientsHealth Condition 1: K00-K95- Diseases of the digestive systemCTRI/2020/03/023759DR GAURAV AGARWA
Completed
Not Applicable
What is the effect of inhalational anaesthetic agents on blood glucose levels in non diabetic patients?Health Condition 1: O- Medical and SurgicalCTRI/2021/12/038579All India Institute of Medical Sciences Raipur105
Active, not recruiting
Not Applicable
Study HZA106851: A Study of the Effects of Inhaled Fluticasone Furoate/GW642444 versus Placebo on the HPA Axis of Adolescent and Adult AsthmaticsAsthmaMedDRA version: 12.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-017669-44-DEGlaxoSmithKline Research & Development Ltd185
Active, not recruiting
Phase 1
The inhaled combination of budesonide-formoterol consists a basic asthma treatment.A helpful specific index for the prognosis of future exacerbation risk and deterioration of lung function,is the Exhaled Nitric Oxide.The objective of the current study is the evaluation of Pulmoton- Elpenhaler in Exhaled Nitric Oxide of patients with bronchial asthma.EUCTR2014-001029-34-GRELPEN Pharmaceutical Co. Inc